stars 1 stars 2 stars 3

SQI Diagnostics, Inc. (TSX-V: SQD; OTCQB: SQIDF) is a precision medicine company that discovers, develops, and commercializes innovative rapid diagnostic testing for healthcare providers, patients, and consumers worldwide. The Company’s proprietary advanced diagnostics target organ transplant, autoimmune disease and COVID-19 testing which include the developmental direct-to-consumer COVID-19 HOME Antibody Test, the RALI-dx™ COVID-19 Severity Triage Test and the COVID-19 RALI-fast™ Severity Triage Point-of-Care (POC) Test.

SQI Diagnostics Questions

The SQI Diagnostics annual revenue was $29.3 million in 2026.

Morlan Reddock is the CFO & VP Investor Relations of SQI Diagnostics.

21 people are employed at SQI Diagnostics.

SQI Diagnostics is based in Toronto, Ontario.

The NAICS codes for SQI Diagnostics are [3254, 62151, 6215, 325413, 62, 325, 32, 621, 32541].

The SIC codes for SQI Diagnostics are [801, 80].

Top SQI Diagnostics Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users